Group
Companies
History
Business model
Mission and vision
Corporate values
Commitment to sport
Research
Pharmaceutical Research
Sucrosomial Technology
Cetylated Fatty Acids
Quality and certifications
Brands
PharmaNutra
Junia Pharma
Alesco
Akern
Investor
INVESTOR RELATIONS
Stock performance
Share capital and Shareholders
Shares study and research
Broker
Financial statements
Presentations
Corporate events
Company presentation
Notice of meetings
SDIR
AIM admission document
MTA prospectus
PRESS
Press releases
Press review
Governance
Code of Ethics
231 Model
Board of Directors and Committees
Company documents
Internal dealing
Shareholders’ meeting
Statutory auditors and Audit firm
Sharholders Agreements
Sustainability
News
Science
Corporate
Events
Social commitment
Careers
Work with us
Job offers
Job application
Group
Companies
History
Business model
Mission and vision
Corporate values
Commitment to sport
Research
Pharmaceutical Research
Sucrosomial Technology
Cetylated Fatty Acids
Quality and certifications
Brands
PharmaNutra
Junia Pharma
Alesco
Akern
Investor
INVESTOR RELATIONS
Stock performance
Share capital and Shareholders
Shares study and research
Broker
Financial statements
Presentations
Corporate events
Company presentation
Notice of meetings
SDIR
AIM admission document
MTA prospectus
PRESS
Press releases
Press review
Governance
Code of Ethics
231 Model
Board of Directors and Committees
Company documents
Internal dealing
Shareholders’ meeting
Statutory auditors and Audit firm
Sharholders Agreements
Sustainability
News
Science
Corporate
Events
Social commitment
Careers
Work with us
Job offers
Job application
it
en
25 March 2024
ANNUAL FINANCIAL REPORT 31/12/2023
10 November 2023
INTERIM MANAGMENT REPORT as of 30 SEPTEMBER 2023
19 September 2023
INTERIM MANAGEMENT REPORT 30/06/2023
13 May 2023
INTERIM FINANCIAL REPORT MARCH 31 2023
31 March 2023
ANNUAL FINANCIAL REPORT 31/12/2022
14 November 2022
INTERIM MANAGEMENT REPORT 30/09/2022
14 September 2022
H1 FINANCIAL REPORT 30/06/2022
12 May 2022
INTERIM MANAGEMENT REPORT 31/03/2022
31 March 2022
ANNUAL FINANCIAL STATEMENTS 31/12/2021
12 November 2021
INTERIM MANAGEMENT REPORT 30/09/2021
13 September 2021
H1 FINANCIAL REPORT 30/06/2021
10 May 2021
INTERIM MANAGEMENT REPORT 31/03/2021
1
2
3
>